Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Accumulated Expenses: 2013-2015

Historic Accumulated Expenses for Tvardi Therapeutics (TVRD) over the last 3 years, with Dec 2015 value amounting to $1.2 million.

  • Tvardi Therapeutics' Accumulated Expenses rose 138.89% to $1.2 million in Q4 2015 from the same period last year, while for Dec 2015 it was $1.2 million, marking a year-over-year increase of 138.89%. This contributed to the annual value of $1.2 million for FY2015, which is 138.89% up from last year.
  • Latest data reveals that Tvardi Therapeutics reported Accumulated Expenses of $1.2 million as of FY2015, which was up 138.89% from $504,000 recorded in FY2014.
  • Tvardi Therapeutics' 5-year Accumulated Expenses high stood at $1.2 million for FY2015, and its period low was $83,000 during FY2013.
  • Its 3-year average for Accumulated Expenses is $597,000, with a median of $504,000 in 2014.
  • Data for Tvardi Therapeutics' Accumulated Expenses shows a peak YoY skyrocketed of 507.23% (in 2014) over the last 5 years.
  • Tvardi Therapeutics' Accumulated Expenses (Yearly) stood at $83,000 in 2013, then soared by 507.23% to $504,000 in 2014, then surged by 138.89% to $1.2 million in 2015.